Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 20 for “"therapeutics development"”.

  1. Metal Homeostasis in Gram Positive Pathogens and Therapeutics Development

    … Although vaccination and antimicrobial development remain important strategies to combat these pathogens, the success of such interventions depends on understanding how environmental conditions influence bacterial survival, persistence, and virulence. In this study, we investigated the …

    arizona-thes Repository record for Metal Homeostasis in Gram Positive Pathogens and Therapeutics Development (opens in a new tab)

  2. Quantitative pharmacokinetic-pharmacodynamic modeling to optimize targeted PI3K-AKT-mTOR oncology therapeutics development

    … cancer types. Massive efforts dedicated to the development of drugs targeting PI3K signaling, however, the number of approved inhibitors remains limited. Thesis objectives were to acquire a better understanding of the PI3K/AKT/mTOR pathway dynamic response by developing mechanistic preclinical …

    ubc Repository record for Quantitative pharmacokinetic-pharmacodynamic modeling to optimize targeted PI3K-AKT-mTOR oncology therapeutics development (opens in a new tab) Download PDF for Quantitative pharmacokinetic-pharmacodynamic modeling to optimize targeted PI3K-AKT-mTOR oncology therapeutics development (opens in a new tab)

  3. Representation of Minoritized People with Cystic Fibrosis in CF Therapeutics Development Network Clinical Studies

    Black and Hispanic people with CF (PwCF) experience a greater burden of worse health outcomes related to pulmonary disease compared to White, non-Hispanic PwCF. Prior evidence suggests that these communities are underrepresented in clinical research in CF. We used clinical study data from four …

    washington Repository record for Representation of Minoritized People with Cystic Fibrosis in CF Therapeutics Development Network Clinical Studies (opens in a new tab)

  4. Solution structure and biochemistry of an intramembrane aspartyl protease (IAP)

    … of life, including cell differentiation, development and metabolism. IPs are attractive targets for therapeutics development and have been implicated in the pathogenesis of human diseases, such as Alzheimer’s disease, Hepatitis C, malaria and a variety of cancers. Despite their broad …

    gatech Repository record for Solution structure and biochemistry of an intramembrane aspartyl protease (IAP) (opens in a new tab)

  5. From Chemo- to Site-Selectivity: Novel Applications of Tetrazines and Triazines

    … applicable in many fields like chemical biology, therapeutics development and material science. In particular, chemically functionalized peptides or proteins are of interest because they possess improved properties compared to their unmodified counterparts. Proteins can be constructed from the 20 …

    radboud Repository record for From Chemo- to Site-Selectivity: Novel Applications of Tetrazines and Triazines (opens in a new tab)

  6. Modulating the innate immune response and bacterial fitness by combinatorial engineering of endotoxin

    … of immunostimulatory molecules for vaccine and therapeutics development as well as for a deeper understanding of bacterial membrane biogenesis.

    texas Repository record for Modulating the innate immune response and bacterial fitness by combinatorial engineering of endotoxin (opens in a new tab)

  7. In Vitro Cortical Networks for Disease Modeling and Drug Evaluation

    … used as media for discovery of drugs or novel therapeutics. Development of in vitro models for various neurological diseases that enable efficient pharmacological or toxicological screening has been ongoing but challenging. Recognizing the potential benefit of in vitro disease models, …

    unt Repository record for In Vitro Cortical Networks for Disease Modeling and Drug Evaluation (opens in a new tab)

  8. From bench to therapy : exploring mouse models and AAV9 gene therapy for Charcot-Marie-Tooth disease type 2E

    … onset and severity. To date, no effective therapeutics have been approved for CMT2E. To advance therapeutics' development and better understand the underlying biology of disease development, we generated novel CMT2E mouse models: Nefl⁺⸍ᴱ³⁹⁷ᴷ and Neflᴱ³⁹⁷ᴷ⸍ᴱ³⁹⁷ᴷ. An orthologous mutation in …

    missouri Repository record for From bench to therapy : exploring mouse models and AAV9 gene therapy for Charcot-Marie-Tooth disease type 2E (opens in a new tab)

  9. Functional Optical Imaging of the Developing Mouse Cortex in Health and Disease

    Neurodevelopmental disorders (NDDs) are a heterogeneous family of disorders characterized by the presence of abnormal developmental trajectories. Functional connectivity (FC) neuroimaging provides a minimally-invasive method by which to investigate the progression of these disorders and identify …

    wustl Repository record for Functional Optical Imaging of the Developing Mouse Cortex in Health and Disease (opens in a new tab)

  10. Adrenergic control of energy metabolism in humans

    … metabolic properties for potential anti-obesity therapeutics development.

    unsw Repository record for Adrenergic control of energy metabolism in humans (opens in a new tab)

  11. Induced pluripotent stem cell based modeling of gastrointestinal disease using human intestinal organoids

    … better recapitulate human physiology and key developmental milestones. These iPSC-derived cells contain the exact genetic background of a particular donor or patient and are easily amenable to gene-editing, making them particularly advantageous in comparison to non-human model organisms or in …

    bu Repository record for Induced pluripotent stem cell based modeling of gastrointestinal disease using human intestinal organoids (opens in a new tab)

  12. Enhanced Proteomics Resolves KCC2 as a Novel Therapeutic Target for Traumatic Brain Injury

    The development of traumatic brain injury (TBI) therapeutics and effective translation to clinic remains stubbornly elusive despite the high prevalence of TBI within the United States and across the globe. Interventions must be devised around testable targets, appropriately timed to intercede on …

    vcu Repository record for Enhanced Proteomics Resolves KCC2 as a Novel Therapeutic Target for Traumatic Brain Injury (opens in a new tab)

  13. Cell surface display in biomedical applications and biofuels production

    … biocatalysis, as well as vaccine and therapeutics development. Compared to intracellular expression, the main advantages of this technology include direct access to large target molecules that cannot diffuse into the cell, stabilization of enzymes or proteins by attaching them to the …

    uiuc Repository record for Cell surface display in biomedical applications and biofuels production (opens in a new tab)

  14. Generation of recombinant human respiratory syncytial viruses to study antigenic subtype differences, attachment glycoprotein evolution, and polymerase localization

    … which would contribute to HRSV vaccine and therapeutics development. The differences in the fitness of A and B antigenic subtypes of HRSV and how it affects the regional circulation pattern is not well understood. To study and compare the two subtypes, it is important to use clinically …

    bu Repository record for Generation of recombinant human respiratory syncytial viruses to study antigenic subtype differences, attachment glycoprotein evolution, and polymerase localization (opens in a new tab)

  15. Investigation of the Mesenchymal Manifestations of Tuberous Sclerosis Complex using Tissue-Engineered Disease Models

    … I find that loss of TSC1/2 affects multiple developmental processes in the renal epithelial, stromal, and glial compartments. First, loss of TSC1/2 leads to an expanded stroma by favouring stromal cell fate acquisition and alters terminal stromal cell identity. Second, epithelial cells in the …

    ottawa-retro Repository record for Investigation of the Mesenchymal Manifestations of Tuberous Sclerosis Complex using Tissue-Engineered Disease Models (opens in a new tab)